Latest News
Sverica Capital Management, a growth-orientated private equity firm focused on the lower middle market, has promoted Ryan Harstad and Gregg Osenkowski to the position of Partner, effective immediately.
With over 11 years of experience in the private equity space, Harstad joined the Sverica San Francisco office 2011. He focuses on sourcing and evaluating new investments, transaction execution and portfolio company operations for technology, technology services and software companies.
Osenkowski joined Sverica’s Boston office in 2006 and focuses on sourcing and managing healthcare investments. He has thirteen years of private equity experience and currently sits on the Board of Women’s
Endless, a private equity investor, has acquired Victoria Plum from TPG Capital.
Founded in 2001, Victoria Plum provides a range of predominantly own-branded bathroom products, including bathroom suites, bathroom furniture and accessories. Victoria Plum currently employs more than 300 people and the investment from Endless will support the online bathroom retailer’s continued growth.
Endless has acquired the entire issued share capital of the business for an undisclosed sum and will work with the management team to continue investing in its people, digital and retail experience and expanding its product and services offering.
The transaction was led by Matthew
ACA Compliance Group (ACA) is expanding its European presence with the opening of a new office in Birmingham.
The office will allow ACA to offer a full suite of services designed to strengthen and streamline financial services firms’ governance, risk and compliance arrangements.
Key to the services offered from the Birmingham office will be ACA’s Analysis and Review Centre (ARC). The ARC helps to reduce the workload of CCOs and in-house compliance teams by allow them to pass on executional regulatory responsibilities to ACA. This on-demand service aims to provide an efficient, scalable and cost-effective compliance across the UK.
Maven Capital Partners (Maven), one of the UK’s leading SME finance providers, has added to its team with the appointment of James Rosthorn and Dean Cox as Investment Managers.
Chartered Accountant, Rosthorn, joins Maven as an Investment Manager based in the Manchester and Lancashire offices and will be responsible for new investments across the North of England. Prior to joining Maven, he was a Corporate Finance Advisor at Top 10 Accounting firm, Mazars, where he advised owner managed businesses on sales, acquisitions, fundraising and MBOs.
Qualified Solicitor and Corporate Finance Masters, Cox, is Maven’s second appointment to the investment
UK mid-market private equity investor Livingbridge has closed the Livingbridge Enterprise 3 fund with total capital commitments of GBP334 million, an increase of 50 per cent on its predecessor fund, Livingbridge Enterprise 2, a 2015 vintage fund.
Enterprise 3, which will leverage Livingbridge’s experience, international network and growth acceleration capabilities, will invest in fast growth SMEs primarily in the UK, with an enterprise value of up to GBP50 million across the firm’s sectors: TMT; services; consumer markets; and healthcare and education.
The fund has attracted a globally diversified range of high-quality investors including corporate and public pension funds, endowments, fund
iM Global Partner, an investment and development platform focused on acquiring strategic investments in traditional and alternative investment firms in the US, Europe and Asia, has created a new Client Servicing Department dedicated to international distribution.
Clément Labouret (pictured) has been appointed as Client Services Manager to lead the new department.
iM Global Partner has grown from from three people and USD1.5 billion of assets under management in December 2015 to 22 people and USD10.7 billion of assets under management today.
Based in Paris, Labouret will support the International Distribution team and coordinate with the Partners of iM Global
Ingenious’ Infrastructure Ventures EIS Service has invested in Winnow, the technology company behind Winnow Vision, an artificial intelligence tool helping chefs cut food waste in half, as it completes its series B round of funding at USD12 million.
Other co-investors in this fund raising round include Ingka Investments, Mustard Seed, Circularity Capital, D-Ax in addition to Ingenious. This follows a recent loan from The European Investment Bank (EIB) and in total means the firm has raised USD20 million in the last month, allowing it to focus on global markets.
Launched in a single staff restaurant in 2013, Winnow has been
KKR has made new leadership appointments in its flagship private equity businesses in the Americas, Europe and Asia-Pacific.
Henry Kravis and George Roberts, Co-Chief Executive Officers and Co-Founders of KKR, say: “While our firm has evolved over the years, private equity is where it all began. Today, this asset class remains as important as ever as it continues to support companies and communities and meet the critical needs of our fund investors. We believe these promotions will enable us to maintain our leadership in private equity for decades to come.”
KKR currently has USD75 billion in private equity assets
Idinvest Partners, aa investor in SMEs across Europe, has anheldnounced the final closing of its third digital fund at EUR350 million, having surpassed its initial fundraising target of EUR300 million.
The fund, managed by a team of nine investors, has attracted many new LPs from Europe, Asia, the Middle East and North America. It has also been highly successful among investors who, following their participation in the previous fund, extended their commitment.
The final close of the Idinvest Digital Fund III has surpassed that of its predecessor, the Idinvest Digital Fund II, which secured EUR154 million.
Benoist Grossmann,
European venture capital firm Sofinnova Partners has closed its latest early-stage healthcare fund Sofinnova Capital IX, oversubscribed at EUR333 million.
The firm now has more than EUR2 billion under management with more than EUR1 billion raised in the last four years across its platform of life sciences funds.
Pursuing the strategy it has consistently applied over the years for its flagship early-stage Capital funds, Sofinnova Capital IX will invest in the healthcare industry and more specifically in the biopharmaceutical and medical device sectors. Sofinnova Partners will seek to invest as a founding and lead investor in start-ups and corporate
Special Reports
Featured
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
